Supriya Lifescience Limited (SUPRIYA.NS)
INR 732.95
(3.08%)
INR 732.95
(3.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.57 Billion INR | 34.14% |
| 2022 | 1.17 Billion INR | -42.66% |
| 2021 | 2.04 Billion INR | 22.81% |
| 2020 | 1.66 Billion INR | 65.05% |
| 2019 | 1 Billion INR | 64.99% |
| 2018 | 610.98 Million INR | 266.05% |
| 2017 | 166.91 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 599.73 Million INR | 3.61% |
| 2024 Q1 | 578.86 Million INR | 12.2% |
| 2023 Q1 | 405.36 Million INR | -24.93% |
| 2023 Q4 | 515.9 Million INR | 27.09% |
| 2023 Q3 | 405.93 Million INR | 34.24% |
| 2023 Q2 | 302.38 Million INR | -25.4% |
| 2023 FY | 1.57 Billion INR | 34.14% |
| 2022 Q4 | 540 Million INR | 295.4% |
| 2022 Q3 | 136.57 Million INR | -73.31% |
| 2022 Q2 | 511.74 Million INR | 80.44% |
| 2022 Q1 | 283.61 Million INR | -64.38% |
| 2022 FY | 1.17 Billion INR | -42.66% |
| 2021 Q2 | 946.41 Million INR | 534.54% |
| 2021 FY | 2.04 Billion INR | 22.81% |
| 2021 Q1 | 149.15 Million INR | -76.33% |
| 2021 Q4 | 796.24 Million INR | 122.56% |
| 2021 Q3 | 357.77 Million INR | -62.2% |
| 2020 Q3 | 210.38 Million INR | 0.0% |
| 2020 FY | 1.66 Billion INR | 65.05% |
| 2020 Q4 | 630.08 Million INR | 199.5% |
| 2019 FY | 1 Billion INR | 64.99% |
| 2018 FY | 610.98 Million INR | 266.05% |
| 2017 FY | 166.91 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biocon Limited | 50.83 Billion INR | 96.908% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 53.394% |
| Concord Biotech Limited | 6.26 Billion INR | 74.901% |
| Dishman Carbogen Amcis Limited | -413 Million INR | 480.545% |
| Jubilant Ingrevia Limited | 2.93 Billion INR | 46.542% |
| Lyka Labs Limited | 29.13 Million INR | -5295.297% |
| Panacea Biotec Limited | - INR | -Infinity% |
| Piramal Pharma Limited | 4.31 Billion INR | 63.578% |
| SMS Lifesciences India Limited | 359.47 Million INR | -337.211% |
| Syngene International Limited | 6.46 Billion INR | 75.701% |
| TAKE Solutions Limited | -213.49 Million INR | 836.17% |
| Zota Health Care Limited | -129.79 Million INR | 1310.862% |